Association Between Parathyroid Hormone Levels and Inflammatory Markers Among US Adults

Overview

Journal Mediators Inflamm

Publisher Wiley

Specialties Biochemistry
Pathology

Date 2014 May 1

PMID 24782595

Citations 35

Authors

Shih-Ping Cheng

Chien-Liang Liu

Tsang-Pai Liu

Yi-Chiung Hsu

Jie-Jen Lee

Affiliations

Soon will be listed here.

Abstract

Background And Aims: High levels of parathyroid hormone (PTH) appear to be associated with an increased mortality. Previous studies concerning the relationship of inflammatory markers with hyperparathyroidism have yielded inconsistent results. This study investigated whether serum PTH concentrations were independently associated with several inflammatory markers among the US adults.

Materials And Methods: Using data from the National Health and Nutrition Examination Survey, we examined the relation between serum PTH and C-reactive protein (CRP), red cell distribution width (RDW), and platelet-to-lymphocyte ratio (PLR) levels with weighted linear regression. Additionally, we examined the relation with increased modified Glasgow Prognostic Score (mGPS) by using weighted logistic regression.

Results: CRP, RDW, and PLR values increased with increasing serum PTH concentration. After extensively adjusting for covariates, CRP and RDW increased linearly and across PTH categories (all P < 0.001), while PLR marginally increased (P = 0.190 and P = 0.095 using PTH as a categorical and continuous variable, resp.). The odds ratio of increased mGPS was 1.11 and 1.31 across PTH categories and with increasing PTH levels continuously.

Conclusion: These nationally representative data indicate that serum PTH levels are independently associated with several inflammatory markers in the US population. The casual relationship between PTH levels and inflammation remains to be elucidated.

Citing Articles

The Importance of Biochemical Parameters, Immunonutritional Status, and Social Support for Quality of Life in Chronic Hemodialysis Patients.

Babovic B, Belada Babovic N, Tomovic F, Radovanovic S, Debeljevic M, Mustur D Medicina (Kaunas). 2024; 60(11).

PMID: 39596936 PMC: 11596489. DOI: 10.3390/medicina60111751.

Effect of parathyroidectomy on serum inflammatory and metabolic dysfunction markers in patients with primary hyperparathyroidism.

Deniz M, Ozder N, Ersoy O, Narli Z Arch Endocrinol Metab. 2024; 68:e240124.

PMID: 39529989 PMC: 11554364. DOI: 10.20945/2359-4292-2024-0124.

Bone Disease in Primary Hyperparathyroidism-Changes Occurring in Bone Metabolism and New Potential Treatment Strategies.

Iwanowska M, Kochman M, Szatko A, Zgliczynski W, Glinicki P Int J Mol Sci. 2024; 25(21).

PMID: 39519190 PMC: 11546563. DOI: 10.3390/ijms252111639.

Healthy eating index and bone health markers in adults with metabolically healthy and unhealthy obese phenotypes.

Suhett L, Cheung M, Dall R, Sukumar D Hum Nutr Metab. 2024; 32:200186.

PMID: 39421727 PMC: 11484842. DOI: 10.1016/j.hnm.2023.200186.

Hyperparathyroidism and Peripheral Arterial Disease.

Antignani P, Jezovnik M, Blinc A, Mikhailidis D, Anagnostis P, Schernthaner G Curr Vasc Pharmacol. 2024; 22(2):88-94.

PMID: 38284694 DOI: 10.2174/0115701611280905231227045826.

References

Gandhi S, Myers R . Can parathyroid hormone be used as a biomarker for heart failure?. Heart Fail Rev. 2012; 18(4):465-73. DOI: 10.1007/s10741-012-9336-9. View

Yousuf O, Mohanty B, Martin S, Joshi P, Blaha M, Nasir K . High-sensitivity C-reactive protein and cardiovascular disease: a resolute belief or an elusive link?. J Am Coll Cardiol. 2013; 62(5):397-408. DOI: 10.1016/j.jacc.2013.05.016. View

Fliser D, Franek E, Fode P, Stefanski A, Schmitt C, Lyons M . Subacute infusion of physiological doses of parathyroid hormone raises blood pressure in humans. Nephrol Dial Transplant. 1997; 12(5):933-8. DOI: 10.1093/ndt/12.5.933. View

Ogard C, Engelmann M, Kistorp C, Nielsen S, Vestergaard H . Increased plasma N-terminal pro-B-type natriuretic peptide and markers of inflammation related to atherosclerosis in patients with primary hyperparathyroidism. Clin Endocrinol (Oxf). 2005; 63(5):493-8. DOI: 10.1111/j.1365-2265.2005.02363.x. View

Castell J, Gomez-Lechon M, David M, Andus T, Geiger T, Trullenque R . Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett. 1989; 242(2):237-9. DOI: 10.1016/0014-5793(89)80476-4. View

Chen J, Sambrook P, March L, Cameron I, Cumming R, Simpson J . Hypovitaminosis D and parathyroid hormone response in the elderly: effects on bone turnover and mortality. Clin Endocrinol (Oxf). 2007; 68(2):290-8. DOI: 10.1111/j.1365-2265.2007.03040.x. View

Silver J, Rodriguez M, Slatopolsky E . FGF23 and PTH--double agents at the heart of CKD. Nephrol Dial Transplant. 2012; 27(5):1715-20. PMC: 3471546. DOI: 10.1093/ndt/gfs050. View

McCarty M . Secondary hyperparathyroidism promotes the acute phase response -- a rationale for supplemental vitamin D in prevention of vascular events in the elderly. Med Hypotheses. 2005; 64(5):1022-6. DOI: 10.1016/j.mehy.2004.03.041. View

Klinger M, Jelkmann W . Role of blood platelets in infection and inflammation. J Interferon Cytokine Res. 2002; 22(9):913-22. DOI: 10.1089/10799900260286623. View

10.

Perlstein T, Weuve J, Pfeffer M, Beckman J . Red blood cell distribution width and mortality risk in a community-based prospective cohort. Arch Intern Med. 2009; 169(6):588-94. PMC: 3387573. DOI: 10.1001/archinternmed.2009.55. View

11.

Turkmen K, Erdur F, Ozcicek F, Ozcicek A, Akbas E, Ozbicer A . Platelet-to-lymphocyte ratio better predicts inflammation than neutrophil-to-lymphocyte ratio in end-stage renal disease patients. Hemodial Int. 2013; 17(3):391-6. DOI: 10.1111/hdi.12040. View

12.

Almqvist E, Bondeson A, Bondeson L, Svensson J . Increased markers of inflammation and endothelial dysfunction in patients with mild primary hyperparathyroidism. Scand J Clin Lab Invest. 2010; 71(2):139-44. DOI: 10.3109/00365513.2010.543694. View

13.

Emam A, Mousa S, Ahmed K, Al-Azab A . Inflammatory biomarkers in patients with asymptomatic primary hyperparathyroidism. Med Princ Pract. 2011; 21(3):249-53. DOI: 10.1159/000334588. View

14.

Izquierdo M, Perez-Gomez M, Sanchez-Nino M, Sanz A, Ruiz-Andres O, Poveda J . Klotho, phosphate and inflammation/ageing in chronic kidney disease. Nephrol Dial Transplant. 2012; 27 Suppl 4:iv6-10. DOI: 10.1093/ndt/gfs426. View

15.

Azab B, Shah N, Akerman M, McGinn Jr J . Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis. 2012; 34(3):326-34. DOI: 10.1007/s11239-012-0718-6. View

16.

Cawthon P, Parimi N, Barrett-Connor E, Laughlin G, Ensrud K, Hoffman A . Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. J Clin Endocrinol Metab. 2010; 95(10):4625-34. PMC: 3050100. DOI: 10.1210/jc.2010-0638. View

17.

Chertok-Shacham E, Ishay A, Lavi I, Luboshitzky R . Biomarkers of hypercoagulability and inflammation in primary hyperparathyroidism. Med Sci Monit. 2008; 14(12):CR628-32. View

18.

Mendoza J, Isakova T, Ricardo A, Xie H, Navaneethan S, Anderson A . Fibroblast growth factor 23 and Inflammation in CKD. Clin J Am Soc Nephrol. 2012; 7(7):1155-62. PMC: 3386678. DOI: 10.2215/CJN.13281211. View

19.

Halabe A, Shohat B . Effect of parathyroid adenoma excision on interleukin-6 (IL-6) and IL-2 receptor levels. Metabolism. 2000; 49(2):192-4. DOI: 10.1016/s0026-0495(00)91247-2. View

20.

Patel K, Semba R, Ferrucci L, Newman A, Fried L, Wallace R . Red cell distribution width and mortality in older adults: a meta-analysis. J Gerontol A Biol Sci Med Sci. 2009; 65(3):258-65. PMC: 2822283. DOI: 10.1093/gerona/glp163. View